Abbonarsi

Barriers and facilitators to the implementation of electronic monitors to improve adherence and health outcomes in patients with tuberculosis: a systematic review - 27/02/25

Doi : 10.1016/S1473-3099(24)00587-5 
Wenhui Li, MPH a, , Shishi Wu, PhD b, , Min Su, ProfPhD a, , Ammar Saad, MSc c, Weile Zhang, BPA a, Xiaojing Fan, ProfPhD d, Renzhong Li, MS e, Yulong Gao, MSc f, Xiaolin Wei, ProfPhD b,
a School of Public Administration, Inner Mongolia University, Hohhot, China 
b Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada 
c School of Epidemiology and Public Health, University of Ottawa, ON, Canada 
d School of Public Policy and Administration, Xi’an Jiaotong University, Xi’an, China 
e National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China 
f Department of Infectious Disease Control and Prevention, Inner Mongolia Center for Disease Control and Prevention, Hohhot, China 

* Correspondence to: Prof Min Su, School of Public Administration, Inner Mongolia University, Hohhot 010070, China School of Public Administration Inner Mongolia University Hohhot 010070 China ** Prof Xiaolin Wei, Dalla Lana School of Public Health, University of Toronto, Toronto, ON M5T 3M7, Canada Dalla Lana School of Public Health University of Toronto Toronto ON M5T 3M7 Canada

Summary

Tuberculosis remains a public health concern, and electronic monitors show promise in improving treatment adherence and health outcomes among patients with tuberculosis. This Review aims to provide a comprehensive understanding of the implementation barriers and facilitators of electronic monitors for patients with tuberculosis, by use of an implementation science framework. A literature search was done across Ovid MEDLINE, CINAHL, Embase, Cochrane Library, Web of Science, and Global Health databases from their inception to April 25, 2024. Studies reporting on the barriers and facilitators of electronic monitors among patients with tuberculosis were included and study characteristics and evidence were tabulated. Implementation factors were synthesised applying the updated Consolidated Framework for Implementation Research framework. This Review was registered with PROSPERO (CRD42023395747). Of 8816 records, 31 eligible studies were included. Barriers mainly included the information technology infrastructure, materials, and equipment resources, whereas facilitators included access to knowledge and information, communications, and reflecting and evaluating. Innovation design and patients’ motivation were identified as both common barriers and facilitators. Inter-relationships between these factors were also explored. Cooperative and patient-centred efforts are required to address the barriers identified. Specific recommendations include improving education and training, eliminating stigma, and resolving technical challenges with feedback to boost patients’ treatment adherence and outcomes.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


Crown Copyright © 2025  Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 25 - N° 3

P. e153-e164 - marzo 2025 Ritorno al numero
Articolo precedente Articolo precedente
  • Review of the WHO guideline on preventive chemotherapy for public health control of strongyloidiasis
  • Nathan C Lo, David G Addiss, Dora Buonfrate, Arancha Amor, Melaku Anegagrie, Zeno Bisoffi, Richard S Bradbury, Jennifer Keiser, Stella Kepha, Virak Khieu, Alejandro Krolewiecki, Jean B Mbonigaba, Jose Muñoz, Francisca Mutapi, Valdemiro Novela, Susana Vaz Nery, Luc E Coffeng, Sake J de Vlas, Jessica Bartoszko, Lorenzo Moja, Denise Mupfasoni, Antonio Montresor
| Articolo seguente Articolo seguente
  • Ebola disease: bridging scientific discoveries and clinical application
  • Amanda Rojek, Joshua Fieggen, Paska Apiyo, Séverine Caluwaerts, Robert A Fowler, Pontiano Kaleebu, Richard Kojan, Marta Lado, Teresa Lambe, Jake Dunning, Peter Horby

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.